Search

Your search keyword '"de Min, Cristina"' showing total 37 results

Search Constraints

Start Over You searched for: Author "de Min, Cristina" Remove constraint Author: "de Min, Cristina"
37 results on '"de Min, Cristina"'

Search Results

3. Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two

4. Persistently active interferon‐γ pathway and expansion of T‐bet + B cells in a subset of patients with childhood‐onset systemic lupus erythematosus

5. Efficacy and safety of emapalumab in macrophage activation syndrome

6. Efficacy and safety of emapalumab in macrophage activation syndrome

7. Persistently active interferon‐γ pathway and expansion of T‐bet+ B cells in a subset of patients with childhood‐onset systemic lupus erythematosus.

9. Macrophage Activation Syndrome (MAS) in Systemic Juvenile Idiopathic Arthritis (sJIA): Treatment with Emapalumab, an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody

11. Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated BCGitis

14. Post-Transplant Outcomes of Children with Primary Hemophagocytic Lymphohistiocytosis Treated with Emapalumab

16. Sensitivity Analysis of Overall Response Rate (ORR) with Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis (HLH)

17. Safety of Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis: Results of the Primary Analysis of the Pivotal Phase 2/3 Study

18. Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

19. Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model‐based approach.

22. Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation

24. Safety and Efficacy of Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis

26. NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid

27. NI‐0801, an anti‐chemokine (C‐X‐C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid

28. Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study.

29. A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease

30. Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

31. 51

33. Interferon-gamma (IFNy) in macrophage activation syndrome (MAS) associated with systemic juvenile idiopathic arthritis (sJIA). High levels in patients and a role in a murine mas model

37. Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infection.

Catalog

Books, media, physical & digital resources